Mirae Asset Sharekhan

DOWNLOAD SHAREKHAN APP

Mirae Asset Sharekhan

OPEN DEMAT ACCOUNT

LOGIN / TRADE OPEN ACCOUNT

Follow Us :

Sharekhan

BUY NOW Buy Mercury Laboratories Ltd Stock

Open Free Demat and Trading account in 15 minutes

Overview
Market Data
Market Depth
Option Chain
News
Fundamental
Shareholding Pattern
Corporate Action
Peers
Company Info
FAQ’s

Home Stock Mercury Laboratories Ltd

Thu 21/08/2025,16:1:0

NSE

BSE

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 885.00

Previous Close

₹ 836.80

Volume

12

Mkt Cap ( Rs. Cr)

₹106.20

High

₹ 885.00

Low

₹ 885.00

52 Week High

₹ 1190.00

52 Week Low

₹ 736.00

Book Value Per Share

₹ 446.41

Dividend Yield

0.41

Face Value

₹ 10.00

What’s Your Call?

Collective community sentiment on Mercury Laboratories Ltd

Your Vote -

Buy

33.33%

Hold

33.33%

Sell

33.33%

33.33%

3 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Mercury Laboratories Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

Mercury Laboratories - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

14 Aug 2025, 5:12PM Combined E-Voting result and scrutinizers report of 44th AGM is attached
Mercury Laboratories - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

14 Aug 2025, 5:12PM Combined E-Voting result and scrutinizers report of 44th AGM is attached
Mercury Laboratories - Shareholder Meeting / Postal Ballot-Outcome of AGM

13 Aug 2025, 1:48PM summery of proceedings of 44th AGM is attached
Mercury Laboratories Q1 net profit zooms 185.29% at Rs 0.97 cr

13 Aug 2025, 10:40AM The company reported standalone net profit of Rs 0.97 crore for the quarter ended June 30, 2025 as compared to Rs 0.34 crore in the same period last y
Mercury Laboratories - Unaudited Financial Results For The Quarter Ended On June 30, 2025

13 Aug 2025, 10:32AM Unaudited financial results for the quarter ended on June 30, 2025 is attached here
Mercury Laboratories - Board Meeting Outcome for Outcome Of Board Meeting Held On August 13, 2025

13 Aug 2025, 10:25AM Outcome Of Board Meeting Held On August 13, 2025 is attached
Mercury Laboratories - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

14 Aug 2025, 5:12PM Combined E-Voting result and scrutinizers report of 44th AGM is attached
Mercury Laboratories - Board Meeting Intimation for To Consider And Approve Of Unaudited Financial Results For The Quarter En

5 Aug 2025, 3:11PM Mercury Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2025 ,inter alia, to consider
Mercury Laboratories has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2025

19 Jul 2025, 7:03AM As of June 2025, 73.66% is owned by Indian Promoters and 26.34% by Public. <p align=justify> Top five Promoters holding highest number of shares of Me
Mercury Laboratories - Notice Of 44Th AGM Of The Company To Be Held On August 13, 2025

17 Jul 2025, 5:09PM Submissions of notice of 44th AGM of the company
Mercury Laboratories - Reg. 34 (1) Annual Report.

17 Jul 2025, 4:59PM Submission of 44th Annual Report for the Financial Year 2024-25 under Regulation 34(1) of SEBI (LODR) Regulations, 2015
Mercury Laboratories has declared 35% Final dividend for the financial year March 2025

13 Jul 2025, 6:51PM Mercury Laboratories Ltd. on Wednesday, 14 May 2025, has announced Final dividend of 35 percent on Equity Share, to its shareholders holding shares on
Mercury Laboratories - Shareholder Communication For Tax Deduction On Dividend For The Financial Year 2024-25 And Updation O

10 Jul 2025, 3:43PM Email Communication sent to shareholders about the change in rules of income taxt w.r.t TDS on dividend and for the updation of PAN, Email ID, Mo no a
Mercury Laboratories - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

7 Jul 2025, 11:39AM Certificate under Reg 74(5) of SEBI(DP) Regulation, 2018 received from RTA for the quarter ended on June 30, 2025 is enclosed
Mercury Laboratories - Announcement under Regulation 30 (LODR)-Credit Rating

2 Jul 2025, 12:07PM Pursuant to Regulation 30 read with Sch III of SEB(LODR), 2015, we hereby inform you that CRISIL credit rating agency has reaffirms credit rating on f

Key fundamentals

Evaluate the intrinsic value of Mercury Laboratories Ltd stock

Name	March-25	March-24	March-23	March-22	March-21
Assets	57.6628	56.3341	50.9931	45.4082	43.1344
Liabilities	57.6628	56.3341	50.9931	45.4082	43.1344
Equity	1.2	1.2	1.2	1.2	1.2
Gross Profit	7.0165	9.0303	8.5705	7.1145	9.5907
Net Profit	3.1449	5.6542	5.5788	3.6862	5.3374
Cash From Operating Activities	4.0011	8.225	2.4524	5.1505	8.2138
NPM(%)	4.18	7.48	7.4	6.36	7.78
Revenue	75.1012	75.559	75.3337	57.9238	68.6014
Expenses	68.0847	66.5287	66.7632	50.8093	59.0107
ROE(%)	5.87	10.55	10.41	6.88	9.96

Shareholding Pattern

Corporate Action

XD-Date	Dividend-Amount	Dividend-%	Dividend Yield(%GE)	Price on that day

From Year	To Year	Class of Share	Authorized Capital(Crores)	Issued Capital(Crores)	Paid Up Shares(NOS)	Paid Up Face Value	Paid Up Capital(Crores)
2024	2025	Equity Share	1.20	1.20	1200000.00	10	1.20
2023	2024	Equity Share	1.20	1.20	1200000.00	10	1.20
2022	2023	Equity Share	1.20	1.20	1200000.00	10	1.20
2021	2022	Equity Share	1.20	1.20	1200000.00	10	1.20
2020	2021	Equity Share	1.20	1.20	1200000.00	10	1.20
2019	2020	Equity Share	2.50	1.20	1200000.00	10	1.20
2018	2019	Equity Share	2.50	1.20	1200000.00	10	1.20
2017	2018	Equity Share	2.50	1.20	1200000.00	10	1.20
2016	2017	Equity Share	1.20	1.20	1200000.00	10	1.20
2015	2016	Equity Share	1.20	1.20	1200000.00	10	1.20
2014	2015	Equity Share	1.20	1.20	1200000.00	10	1.20
2013	2014	Equity Share	2.00	1.20	1200000.00	10	1.20
2012	2013	Equity Share	2.00	1.20	1200000.00	10	1.20
2011	2012	Equity Share	2.00	1.20	1200000.00	10	1.20
2010	2011	Equity Share	2.00	1.20	1200000.00	10	1.20
2006	2007	Equity Share	2.00	1.20	1200000.00	10	1.20
2005	2006	Equity Share	2.00	1.20	1200000.00	10	1.20
2004	2005	Equity Share	2.00	1.20	1200000.00	10	1.20
1993	1994	Equity Share	2.00	1.20	1200000.00	10	1.20
1992	1993	Equity Share	2.00	0.80	800000.00	10	0.80

Announcement Date	Price	Bonus Ratio	Record Date

Fund	Market Value(CR)	% Hold
No Records Found

Peers

Other companies within the same industry or sector that are comparable to Mercury Laboratories Ltd

Company	Price	Price (% change)	pe(x)	EV/EBITDA(x)	ROE(%)	ROCE(%)
Albert David Ltd	820.00	0.56	73.61	477.58	301.39	0.62
Lotus Eye Hospital and Institute Ltd	89.17	3.06	290.00	1740.23	3.55	0.00
Bharat Immunological and Biologicals Corporation Ltd	22.70	1.70	0.00	3613.30	-39.50	0.00
Astec Lifesciences Ltd	816.35	-1.52	0.00	1641.08	-604.77	0.00

Company Info

The Company was incorporated on 12.02.1982, under the name and style of Mercury Laboratories Pvt. Limited. The promoters of the Company were MR. Kantilal Bapulal Shah & Mr. Ramanlal Bapulal Shah. The objective of the company is to manufacture all types of pharmaceutical formulations in the form of tablets, capsules, liquid orals, Injectables and Ointments. The Company became a Public Ltd. company on 15th May 1992 and its name was then changed to Mercury Laboratories Limited. 2015 -Mercury Laboratories is been listed in BSE.

The Company was incorporated on 12.02.1982, under the name and style of Mercury Laboratories Pvt. Limited. The promoters of the Company were MR. Kantilal Bapulal Shah & Mr. Ramanlal Bapulal Shah. The objective of the company is to manufacture all types of pharmaceutical formulations in the form of tablets, capsules, liquid orals, Injectables and Ointments. The Company became a Public Ltd. company on 15th May 1992 and its name was then changed to Mercury Laboratories Limited. 2015 -Mercury Laboratories is been listed in BSE.

Read More

Parent Organisation

Mercury Laboratories Ltd.

Founded

12/02/1982

Managing Director

Mr.Rajendra R Shah

NSE Symbol

FAQ

The current price of Mercury Laboratories Ltd is ₹ 885.00.

The 52-week high for Mercury Laboratories Ltd is

The market capitalization of Mercury Laboratories Ltd is currently ₹ 106.20. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Mercury Laboratories Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Mercury Laboratories Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Mercury Laboratories Ltd shares.

The CEO of Mercury Laboratories Ltd is Mr.Rajendra R Shah, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT